Case number 2017-2513
Supernus Pharmaceuticals, Inc. v. TWi Pharmaceuticals, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | SUPERNUS PHARMACEUTICALS, INC. v. TWI PHARMACEUTICALS, INC. [OPINION] [nonprecedential] (0) |
| Oct 16, 2018 | 77 | Mandate issued to the United States District Court for the District of New Jersey. Service as of this date by the Clerk of Court. [557683] [PBC] [Entered: 10/16/2018 02:56 PM] (1) |
| Sep 6, 2018 | 76 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Nonprecedential Opinion).; denying as moot motion to modify protective order [34] filed by Appellee Supernus Pharmaceuticals, Inc. (For the Court: O'Malley, Circuit Judge; Clevenger, Circuit Judge and Stoll, Circuit Judge). [547571] [SJ] [Entered: 09/06/2018 09:18 AM] (16) |
| Aug 6, 2018 | 75 | Submitted after ORAL ARGUMENT by Mr. Donald J. Mizerk for TWi Pharmaceuticals, Inc. and TWi International LLC and Mr. Nicholas F. Giove, Esq. for Supernus Pharmaceuticals, Inc.. Panel: Judge: O'Malley , Judge: Clevenger , Judge: Stoll. [540879] [JCP] [Entered: 08/06/2018 11:17 AM] (0) |
| Jul 20, 2018 | 74 | ORDER filed reserving ruling on motion to modify protective order [34] pending a decision on the merits. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [537168] [JAB] [Entered: 07/20/2018 09:06 AM] (2) |
| Jul 9, 2018 | 73 | Response to oral argument order from the Appellee Supernus Pharmaceuticals, Inc.. Designating Nicholas F. Giove to argue.. Designating 15 minutes for argument. [17-2513] [Nicholas Giove] [Entered: 07/09/2018 05:25 PM] (0) |
| Jul 9, 2018 | 72 | Response to oral argument order from the Appellants TWi International LLC and TWi Pharmaceuticals, Inc.. Designating Donald J. Mizerk to argue.. Designating 11 minutes for argument. Reserving 4 minutes for rebuttal. [17-2513] [Donald Mizerk] [Entered: 07/09/2018 04:21 PM] (0) |
| Jun 21, 2018 | 71 | NOTICE OF CALENDARING. Panel: 1808A. Case scheduled Aug 06, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to oral argument order due: 07/16/2018. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [531183] [JAB] [Entered: 06/21/2018 12:18 PM] (0) |
| Apr 2, 2018 | 70 | Notice from Appellants TWi International LLC and TWi Pharmaceuticals, Inc. regarding conflicts with oral argument (July 13, 2018). Service: 04/02/2018 by email. [509994] [17-2513] [Donald Mizerk] [Entered: 04/02/2018 06:29 PM] (2) |
| Mar 29, 2018 | 67 | Notice from Appellee Supernus Pharmaceuticals, Inc. regarding conflicts with oral argument (July 9-13, 2018). Service: 03/29/2018 by email. [509136] [17-2513] [Nicholas Giove] [Entered: 03/29/2018 01:29 PM] (2) |
| Mar 28, 2018 | 66 | 6 paper copies of the Confidential Joint Appendix in 2 Volumes [63] received from Appellants TWi International LLC and TWi Pharmaceuticals, Inc. [508886] [JCP] [Entered: 03/29/2018 07:56 AM] (0) |
| Mar 27, 2018 | 65 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category.. [508276] [SJ] [Entered: 03/27/2018 01:28 PM] (0) |
| Mar 20, 2018 | 69 | 6 CDs of the Corresponding Briefs (Confidential) [63], [52], [28] received from Appellants TWi International LLC and TWi Pharmaceuticals, Inc. [509564] [JCP] [Entered: 03/30/2018 01:04 PM] (0) |
| Mar 20, 2018 | 68 | 6 CDs of the Corresponding Briefs (Non-Confidential) [64], [53], [29] received from Appellants TWi International LLC and TWi Pharmaceuticals, Inc. [509561] [JCP] [Entered: 03/30/2018 01:02 PM] (0) |
| Mar 19, 2018 | 64 | APPENDIX FILED (2 vols.) for TWi International LLC and TWi Pharmaceuticals, Inc. [59]. Number of Pages: 437. Service: 03/19/2018 by email. [508275] [SJ] [Entered: 03/27/2018 01:26 PM] (437) |
| Mar 19, 2018 | 63 | CONFIDENTIAL JOINT APPENDIX FILED (2 vols.) for TWi International LLC and TWi Pharmaceuticals, Inc. [60]. Number of Pages: 1297. Service: 03/19/2018 by email. The paper copies of the brief should be received by the court on or before 04/03/2018. [508272] [SJ] [Entered: 03/27/2018 01:21 PM] (0) |
| Mar 19, 2018 | 62 | Notice of intent to file corresponding briefs on CD-ROM for Appellee Supernus Pharmaceuticals, Inc.. Service: 03/19/2018 by email. [506336] [17-2513] [Nicholas Giove] [Entered: 03/19/2018 04:56 PM] (4) |
| Mar 19, 2018 | 61 | Notice of intent to file corresponding briefs on CD-ROM for Appellants TWi International LLC and TWi Pharmaceuticals, Inc.. Service: 03/19/2018 by email. [506308] [17-2513] [Donald Mizerk] [Entered: 03/19/2018 04:06 PM] (3) |
| Mar 19, 2018 | 60 | TENDERED from Appellants TWi International LLC and TWi Pharmaceuticals, Inc.. Title: CONFIDENTIAL JOINT APPENDIX Service: 03/19/2018 by email. [506304] [17-2513] [Donald Mizerk] [Entered: 03/19/2018 04:01 PM] (0) |
| Mar 19, 2018 | 59 | TENDERED from Appellants TWi International LLC and TWi Pharmaceuticals, Inc.. Title: JOINT APPENDIX. Service: 03/19/2018 by email. [506303] [17-2513] [Donald Mizerk] [Entered: 03/19/2018 03:58 PM] (437) |
| Mar 19, 2018 | 58 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants TWi International LLC, TWi Pharmaceuticals, Inc. and Appellee Supernus Pharmaceuticals, Inc.. Service: 03/19/2018 by email. [506290] [17-2513] [Donald Mizerk] [Entered: 03/19/2018 03:48 PM] (4) |
| Mar 19, 2018 | 57 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants TWi International LLC and TWi Pharmaceuticals, Inc.. Service: 03/19/2018 by email. [506256] [17-2513] [Donald Mizerk] [Entered: 03/19/2018 03:13 PM] (3) |
| Mar 19, 2018 | 56 | 6 CDs of the Corresponding Confidential Response Brief [45] received from Appellee Supernus Pharmaceuticals, Inc. [506165] [SJL] [Entered: 03/19/2018 12:08 PM] (0) |
| Mar 19, 2018 | 55 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Supernus Pharmaceuticals, Inc.. Service: 03/19/2018 by email. [506128] [17-2513] [Nicholas Giove] [Entered: 03/19/2018 10:44 AM] (3) |
| Mar 16, 2018 | 54 | 6 paper copies of the Confidential Reply Brief [52] received from Appellants TWi International LLC and TWi Pharmaceuticals, Inc. [506127] [SJL] [Entered: 03/19/2018 10:42 AM] (0) |
| Mar 9, 2018 | 53 | REPLY BRIEF FILED for Appellants TWi International LLC and TWi Pharmaceuticals, Inc. [51]. Number of Pages: 32. Service: 03/09/2018 by email. Appendix is due 03/19/2018. [505480] [SJ] [Entered: 03/15/2018 11:36 AM] (43) |
| Mar 9, 2018 | 52 | CONFIDENTIAL REPLY BRIEF FILED for Appellants TWi International LLC and TWi Pharmaceuticals, Inc. [50]. Number of Pages: 32. Service: 03/09/2018 by email. The paper copies of the brief should be received by the court on or before 03/23/2018. [505479] [SJ] [Entered: 03/15/2018 11:34 AM] (0) |
| Mar 9, 2018 | 51 | TENDERED from Appellants TWi International LLC and TWi Pharmaceuticals, Inc.. Title: REPLY BRIEF. Service: 03/09/2018 by email. [504008] [Donald Mizerk] [Entered: 03/09/2018 06:34 PM] (43) |
| Mar 9, 2018 | 50 | TENDERED from Appellants TWi International LLC and TWi Pharmaceuticals, Inc.. Title: CONFIDENTIAL REPLY BRIEF Service: 03/09/2018 by email. [504007] [Donald Mizerk] [Entered: 03/09/2018 06:32 PM] (0) |
| Feb 21, 2018 | 49 | ORDER filed. The motion [47] is granted. The reply brief is due March 9, 2018. Service: 02/21/2018 by clerk. [499874] [LMS] [Entered: 02/21/2018 03:25 PM] (2) |
| Feb 20, 2018 | 48 | 6 paper copies of the Confidential Opening Response Brief [45] received from Appellee Supernus Pharmaceuticals, Inc. [499581] [JCP] [Entered: 02/21/2018 08:13 AM] (0) |
| Feb 15, 2018 | 47 | MOTION of Dustin L. Taylor Appellants TWi International LLC and TWi Pharmaceuticals, Inc. to extend the time to 03/09/2018 at 11:59 pm to file the reply brief. Any response is due within 10 days of service [Consent: opposed]. Service: 02/15/2018 by email. [498239] [Dustin Taylor] [Entered: 02/15/2018 04:55 PM] (8) |
| Feb 9, 2018 | 46 | BRIEF FILED for Appellee Supernus Pharmaceuticals, Inc. [44]. Number of Pages: 81. Service: 02/09/2018 by email. Appellants’ reply brief is due 02/23/2018. [497727] [CAB] [Entered: 02/14/2018 03:25 PM] (99) |
| Feb 9, 2018 | 45 | CONFIDENTIAL BRIEF FILED for Appellee Supernus Pharmaceuticals, Inc. [43]. Number of Pages: 81. Service: 02/09/2018 by email. The paper copies of the brief should be received by the court on or before 02/22/2018. [497722] [CAB] [Entered: 02/14/2018 03:20 PM] (0) |
| Feb 9, 2018 | 44 | TENDERED from Appellee Supernus Pharmaceuticals, Inc.. Title: RESPONSE BRIEF. Service: 02/09/2018 by email. [496680] [Nicholas Giove] [Entered: 02/09/2018 12:48 PM] (99) |
| Feb 9, 2018 | 43 | TENDERED from Appellee Supernus Pharmaceuticals, Inc.. Title: CONFIDENTIAL RESPONSE BRIEF Service: 02/09/2018 by email. [496679] [Nicholas Giove] [Entered: 02/09/2018 12:46 PM] (0) |
| Jan 30, 2018 | 42 | ORDER filed. The motion [34] is deferred to the merits panel assigned to hear this case. A copy of the motion papers and this order shall be transmitted to the merits panel.; - FOR CALENDAR. (Per Curiam). Service: 01/30/2018 by clerk. [493836] [NL] [Entered: 01/30/2018 05:32 PM] (3) |
| Jan 10, 2018 | 40 | REPLY of Appellee Supernus Pharmaceuticals, Inc. to response filed by Appellants in 17-2513 , Doc. No [38]. Service: 01/10/2018 by email. [488763] [Nicholas Giove] [Entered: 01/10/2018 03:51 PM] (18) |
| Jan 10, 2018 | 41 | Sealed or confidential document received [Supernus's Reply in Support of Its Motion to Modify the District Court's Protective Order Under Federal Circuit Rule 11(e)] (corresponding to Doc No. [40]) for Appellee Supernus Pharmaceuticals, Inc.. Service: 01/10/2018 by email. [488764] [Nicholas Giove] [Entered: 01/10/2018 03:54 PM] (0) |
| Jan 5, 2018 | 39 | Sealed or confidential document received [Confidential Response of Appellants to Appellee's Motion to Modify] (corresponding to Doc No. [38]) for Appellants TWi International LLC and TWi Pharmaceuticals, Inc.. Service: 01/05/2018 by email. [487791] [Donald Mizerk] [Entered: 01/05/2018 07:32 PM] (0) |
| Jan 5, 2018 | 38 | RESPONSE of Appellants TWi International LLC and TWi Pharmaceuticals, Inc. to the motion to modify protective order [34] filed by Appellee Supernus Pharmaceuticals, Inc. in 17-2513. Service: 01/05/2018 by email. [487790] [Donald Mizerk] [Entered: 01/05/2018 07:28 PM] (132) |
| Dec 27, 2017 | 37 | ORDER filed. The motion for an extension of time [36] is granted. Service: 12/27/2017 by clerk. [485771] [LMS] [Entered: 12/27/2017 11:08 AM] (2) |
| Dec 26, 2017 | 36 | MOTION of Appellants TWi International LLC and TWi Pharmaceuticals, Inc. to extend time until 01/05/2018 at 11:59 pm to file (Response to Supernus's Motion to Modify the District Court's Protective Order Under Federal Circuit Rule 11(e)). [Consent: unopposed]. Service: 12/26/2017 by email. [485529] [Dustin Taylor] [Entered: 12/26/2017 01:15 PM] (7) |
| Dec 21, 2017 | 35 | Sealed or confidential document received [Confidential Version of Plaintiff-Appellee Supernus's Motion to Modify the District Court's Protective Order Under Federal Circuit Rule 11(e)] (corresponding to Doc No. [34]) for Appellee Supernus Pharmaceuticals, Inc.. Service: 12/21/2017 by email. [484960] [Nicholas Giove] [Entered: 12/21/2017 04:07 PM] (0) |
| Dec 21, 2017 | 34 | MOTION of Appellee Supernus Pharmaceuticals, Inc. to modify the protective order. Any response is due within 10 days of service [Consent: opposed]. Service: 12/21/2017 by email. [484947] [Nicholas Giove] [Entered: 12/21/2017 03:52 PM] (111) |
| Dec 7, 2017 | 33 | ORDER granting motion to withdraw John A. Sholar, Jr. as counsel [30] filed by Appellants TWi Pharmaceuticals, Inc. and TWi International LLC. Service as of this date by Clerk of Court. [480921] [CAB] [Entered: 12/07/2017 12:08 PM] (2) |
| Dec 5, 2017 | 32 | 6 paper copies of the Confidential Opening Brief [28] received from Appellants TWi International LLC and TWi Pharmaceuticals, Inc. [480311] [CW] [Entered: 12/05/2017 01:06 PM] (0) |
| Dec 5, 2017 | 31 | 4 paper copies of the Non-Confidential Opening Brief [29] received from Appellants TWi International LLC and TWi Pharmaceuticals, Inc. [480310] [CW] [Entered: 12/05/2017 01:06 PM] (0) |
| Dec 4, 2017 | 30 | MOTION of Dustin L. Taylor Appellants TWi International LLC and TWi Pharmaceuticals, Inc. to withdraw counsel John A. Sholar, Jr.. Any response is due within 10 days of service [Consent: not addressed]. Service: 12/04/2017 by email. [480090] [Dustin Taylor] [Entered: 12/04/2017 05:26 PM] (6) |
| Nov 30, 2017 | 29 | BRIEF FILED for Appellants TWi International LLC and TWi Pharmaceuticals, Inc. [27]. Number of Pages: 65. Service: 11/30/2017 by email. Appellee’s response brief is due no later than 02/09/2018. [479895] [CAB] [Entered: 12/04/2017 01:10 PM] (269) |
| Nov 30, 2017 | 28 | CONFIDENTIAL BRIEF FILED for Appellants TWi International LLC and TWi Pharmaceuticals, Inc. [26]. Number of Pages: 65. Service: 11/30/2017 by email. The paper copies of the brief should be received by the court on or before 12/11/2017. [479889] [CAB] [Entered: 12/04/2017 01:01 PM] (0) |
| Nov 30, 2017 | 27 | TENDERED from Appellants TWi International LLC and TWi Pharmaceuticals, Inc.. Title: OPENING BRIEF. Service: 11/30/2017 by email. [479449] [Donald Mizerk] [Entered: 11/30/2017 04:54 PM] (269) |
| Nov 30, 2017 | 26 | TENDERED from Appellants TWi International LLC and TWi Pharmaceuticals, Inc.. Title: CONFIDENTIAL OPENING BRIEF Service: 11/30/2017 by email. [479448] [Donald Mizerk] [Entered: 11/30/2017 04:53 PM] (0) |
| Oct 18, 2017 | 25 | ORDER granting motion to extend time to file appellant/petitioner principal brief [24] filed by Appellants TWi Pharmaceuticals, Inc. and TWi International LLC.; granting motion to set briefing schedule [24] filed by Appellants TWi Pharmaceuticals, Inc. and TWi International LLC.; Appellants’ opening brief is due no later than November 30, 2017. Appellee’s response brief is due no later than February 9, 2018. Appellants’ reply brief is due no later than February 23, 2018. Service: 10/18/2017 by clerk. [468975] [NL] [Entered: 10/18/2017 05:30 PM] (2) |
| Oct 13, 2017 | 24 | MOTION of John A. Sholar, Jr. Appellants TWi International LLC and TWi Pharmaceuticals, Inc. to extend the time to 11/30/2017 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service, to set briefing schedule. Any response is due within 10 days of service [Consent: unopposed]. Service: 10/13/2017 by email. [467790] [John Sholar] [Entered: 10/13/2017 04:29 PM] (10) |
| Oct 13, 2017 | 23 | Notice of Rejection to Appellants TWi International LLC and TWi Pharmaceuticals, Inc., the following document: motion to extend time to file appellant's principal brief and motion to set briefing schedule [22] is REJECTED for filing. Reason(s): Incomplete/outdated Certificate of Interest. Service: 10/13/2017 by clerk. [467780] [CAB] [Entered: 10/13/2017 04:05 PM] (1) |
| Oct 13, 2017 | 22 | MOTION of John A. Sholar, Jr. Appellants TWi International LLC and TWi Pharmaceuticals, Inc. to extend the time to 11/30/2017 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service, to set briefing schedule. Any response is due within 10 days of service [Consent: unopposed]. Service: 10/13/2017 by email. [467680] [John Sholar] [Entered: 10/13/2017 02:18 PM] (8) |
| Oct 13, 2017 | 21 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [467526] [CAB] [Entered: 10/13/2017 09:06 AM] (0) |
| Sep 22, 2017 | 20 | Entry of appearance for Dustin L. Taylor as of counsel for Appellants TWi International LLC and TWi Pharmaceuticals, Inc.. Service: 09/22/2017 by email. [463073] [Dustin Taylor] [Entered: 09/22/2017 04:55 PM] (2) |
| Sep 20, 2017 | 19 | Notice of intent to file corresponding briefs on CD-ROM for Appellants TWi International LLC, TWi Pharmaceuticals, Inc. and Appellee Supernus Pharmaceuticals, Inc.. Service: 09/20/2017 by email. [462523] [John Sholar] [Entered: 09/20/2017 04:32 PM] (4) |
| Sep 19, 2017 | 18 | Entry of appearance for William C. Baton as of counsel for Appellee Supernus Pharmaceuticals, Inc.. Service: 09/19/2017 by email. [462190] [Nicholas Giove] [Entered: 09/19/2017 04:22 PM] (2) |
| Sep 19, 2017 | 17 | Entry of appearance for Charles M. Lizza as of counsel for Appellee Supernus Pharmaceuticals, Inc.. Service: 09/19/2017 by email. [462189] [Nicholas Giove] [Entered: 09/19/2017 04:21 PM] (2) |
| Sep 19, 2017 | 16 | Entry of appearance for Camille Yvette Turner as of counsel for Appellee Supernus Pharmaceuticals, Inc.. Service: 09/19/2017 by email. [462187] [Nicholas Giove] [Entered: 09/19/2017 04:18 PM] (2) |
| Sep 15, 2017 | 15 | Entry of appearance for Donald J. Mizerk as principal counsel for Appellants TWi International LLC and TWi Pharmaceuticals, Inc.. Service: 09/15/2017 by email. [461543] [Donald Mizerk] [Entered: 09/15/2017 05:11 PM] (2) |
| Sep 15, 2017 | 14 | Entry of appearance for Philip D. Segrest, Jr. as of counsel for Appellants TWi International LLC and TWi Pharmaceuticals, Inc.. Service: 09/15/2017 by email. [461542] [Philip Segrest] [Entered: 09/15/2017 05:09 PM] (2) |
| Sep 15, 2017 | 13 | Certificate of Interest for the Appellants TWi International LLC and TWi Pharmaceuticals, Inc.. Service: 09/15/2017 by email. [461539] [John Sholar] [Entered: 09/15/2017 05:03 PM] (3) |
| Sep 15, 2017 | 12 | Docketing Statement for the Appellants TWi International LLC and TWi Pharmaceuticals, Inc.. Service: 09/15/2017 by email. [461538] [John Sholar] [Entered: 09/15/2017 05:02 PM] (4) |
| Sep 15, 2017 | 11 | Transcript Purchase Order Form for the Appellants TWi International LLC and TWi Pharmaceuticals, Inc. indicating that a transcript is already on file. Service: 09/15/2017 by email. [461537] [John Sholar] [Entered: 09/15/2017 05:01 PM] (2) |
| Sep 15, 2017 | 10 | Entry of appearance for John A. Sholar, Jr. as of counsel for Appellants TWi International LLC and TWi Pharmaceuticals, Inc.. Service: 09/15/2017 by email. [461536] [John Sholar] [Entered: 09/15/2017 05:00 PM] (2) |
| Sep 15, 2017 | 9 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entries of appearance Docket Nos. [3], [4], [5], and [6], ERROR: The law firm name on the entries of appearance for Attorneys Nicholas F. Giove, Andrew Scott Roper, Jonathan A. Herstoff, and Kevin Georgek does not match the information on their ECF filer accounts. CORRECTION: ECF filer account information must be updated through www.pacer.gov to reflect correct information or a corrected entry of appearance form filed. [461517] [CAB] [Entered: 09/15/2017 04:27 PM] (0) |
| Sep 15, 2017 | 8 | Docketing Statement for the Appellee Supernus Pharmaceuticals, Inc.. Service: 09/15/2017 by email. [461384] [Nicholas Giove] [Entered: 09/15/2017 02:38 PM] (4) |
| Sep 15, 2017 | 7 | Certificate of Interest for the Appellee Supernus Pharmaceuticals, Inc.. Service: 09/15/2017 by email. [461379] [Nicholas Giove] [Entered: 09/15/2017 02:36 PM] (3) |
| Sep 15, 2017 | 6 | Entry of appearance for Kevin J. Georgek as of counsel for Appellee Supernus Pharmaceuticals, Inc.. Service: 09/15/2017 by email. [461377] [Nicholas Giove] [Entered: 09/15/2017 02:34 PM] (2) |
| Sep 15, 2017 | 5 | Entry of appearance for Jonathan A. Herstoff as of counsel for Appellee Supernus Pharmaceuticals, Inc.. Service: 09/15/2017 by email. [461375] [Nicholas Giove] [Entered: 09/15/2017 02:33 PM] (2) |
| Sep 15, 2017 | 4 | Entry of appearance for Andrew Scott Roper as of counsel for Appellee Supernus Pharmaceuticals, Inc.. Service: 09/15/2017 by email. [461373] [Nicholas Giove] [Entered: 09/15/2017 02:32 PM] (2) |
| Sep 15, 2017 | 3 | Entry of appearance for Nicholas F. Giove as of counsel for Appellee Supernus Pharmaceuticals, Inc.. Service: 09/15/2017 by email. [461372] [Nicholas Giove] [Entered: 09/15/2017 02:30 PM] (2) |
| Sep 15, 2017 | 2 | Entry of appearance for Edgar H. Haug as principal counsel for Appellee Supernus Pharmaceuticals, Inc.. Service: 09/15/2017 by email. [461369] [Nicholas Giove] [Entered: 09/15/2017 02:29 PM] (2) |
| Sep 1, 2017 | 1 | Appeal docketed. Received: 08/31/2017. [458371]Entry of Appearance due 09/15/2017. Certificate of Interest is due on 09/15/2017. Docketing Statement due 09/15/2017. Appellants' brief is due 10/31/2017. [CAB] [Entered: 09/01/2017 03:39 PM] (60) |
